EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity

Jinkyu Jung iD, Orieta Celiku iD, Benjamin I Rubin, Mark R Gilbert

Cancers · 27.05.2024 · 16 (11) · 2029

DOI: 10.3390/cancers16112029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 27.05.2024. Verfasst von Jinkyu Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH, NCI, CCR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) cells are highly invasive, infiltrating the surrounding normal brain tissue, thereby limiting the efficacy of surgical resection and focal radiotherapy. Cysteamine, a small aminothiol molecule that is orally bioavailable and approved for cystinosis, has potential as a cancer treatment by inhibiting tumor cell invasion and metastasis. Here we demonstrate that these potential therapeutic effects of cysteamine are likely due to the inhibition of matrix metalloproteinases (MMPs) in GBM. In vitro assays confirmed that micromolar concentrations of cysteamine were not cytotoxic, enabling the interrogation of the cellular effects without confounding tumor cell loss. Cysteamine’s inhibition of MMP activity, especially the targeting of MMP2, MMP9, and MMP14, was observed at micromolar concentrations, suggesting the mechanism of action in suppressing invasion and cell migration is by inhibition of these MMPs. These findings suggest that achievable micromolar concentrations of cysteamine effectively inhibit cancer cell invasion and migration in GBM, supporting the potential for use as an adjunct cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

brain cancercysteamineglioblastoma (GBM)invasionmatrix metalloproteinase (MMP)migration

Autor:innen und Institutionen

  • Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Ophthalmology, Suburban Hopkins-Hospital, Bethesda, MD 20814, USA.

ORCID-Profile: Jinkyu Jung, Orieta Celiku

Förderung

  • NIH
  • NCI
  • CCR

Zitieren

APA

Jung, J., Celiku, O., Rubin, B. I., & Gilbert, M. R. (2024). Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity. Cancers, 16(11), 2029. https://doi.org/10.3390/cancers16112029

Vancouver

Jung J, Celiku O, Rubin BI, Gilbert MR. Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity. Cancers. 2024;16(11):2029. doi:10.3390/cancers16112029

BibTeX
@article{Jung2024,
  author = {Jung, Jinkyu and Celiku, Orieta and Rubin, Benjamin I and Gilbert, Mark R},
  title = {Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase Activity},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {2029},
  doi = {10.3390/cancers16112029}
}
Kostenlos starten →